JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trumper, L.
Right arrow Articles by Elias, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trumper, L.
Right arrow Articles by Elias, M. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETAMINOPHEN
*ACETYLCYSTEINE
Medline Plus Health Information
*Pain Relievers

Nephrotoxicity of acetaminophen in male Wistar rats: role of hepatically derived metabolites

L Trumper, LA Monasterolo and MM Elias

Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad Nacional de Rosario, Republica Argentina.

The role of hepatically derived metabolites was studied in rats treated with a nephrotoxic dose of acetaminophen (APAP, 1000 mg/kg b.wt. i.p.). Hepatic glutathione (GSH) content 16 h after APAP dosing was significantly decreased (control = 3.83 +/- 0.1, APAP = 2.51 +/- 0.3 mumol/g wet tissue), whereas renal GSH levels were not changed. The role of hepatically derived GSH conjugates was investigated by administering the gamma-glutamyl-transpeptidase inhibitor, acivicin (20 mg/kg b.wt. i.p.). Treatment with acivicin led to a significant decrease in hepatic and renal gamma-glutamyltranspeptidase activity. Administration of acivicin 1 h before APAP administration protected against the alterations of glomerular filtration rate and urea and creatinine plasma levels induced by APAP. The appearance of epithelial cells and granular casts as well as the urinary excretion of protein and glucose were decreased compared with rats not pretreated with acivicin. Hepatocellular damage (evaluated by glutamic pyruvic transaminase levels) induced by APAP was not altered by acivicin pretreatment. APAP plasma levels and its urinary excretion were the same whether the rats were pretreated with acivicin or not. A group of rats was fitted with an exteriorized biliary cannula before APAP administration to study the contribution of the biliary excretion route of APAP metabolites in the APAP-induced renal damage. No differences were observed on APAP-induced renal effects between rats cannulated or not. Our results suggest that hepatically derived APAP metabolites are partially responsible for APAP renal effects. The sinusoidal efflux of these metabolites is also suggested.

Volume 279, Issue 2, pp. 548-554, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Trumper, L. A. Monasterolo, and M. M. Elías
Probenecid Protects against In Vivo Acetaminophen-Induced Nephrotoxicity in Male Wistar Rats
J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 606 - 610.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.